KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) EPS (Weighted Average and Diluted): 2009-2024

Historic EPS (Weighted Average and Diluted) for Charles River Laboratories International (CRL) over the last 16 years, with Dec 2024 value amounting to $0.20.

  • Charles River Laboratories International's EPS (Weighted Average and Diluted) fell 17.29% to $1.10 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.51, marking a year-over-year decrease of 118.85%. This contributed to the annual value of $0.20 for FY2024, which is 97.83% down from last year.
  • Latest data reveals that Charles River Laboratories International reported EPS (Weighted Average and Diluted) of $0.20 as of FY2024, which was down 97.83% from $9.22 recorded in FY2023.
  • In the past 5 years, Charles River Laboratories International's EPS (Weighted Average and Diluted) ranged from a high of $9.48 in FY2022 and a low of $0.20 during FY2024.
  • Over the past 3 years, Charles River Laboratories International's median EPS (Weighted Average and Diluted) value was $9.22 (recorded in 2023), while the average stood at $6.30.
  • In the last 5 years, Charles River Laboratories International's EPS (Weighted Average and Diluted) skyrocketed by 42.01% in 2020 and then slumped by 97.83% in 2024.
  • Charles River Laboratories International's EPS (Weighted Average and Diluted) (Yearly) stood at $7.20 in 2020, then increased by 5.56% to $7.60 in 2021, then increased by 24.74% to $9.48 in 2022, then decreased by 2.74% to $9.22 in 2023, then slumped by 97.83% to $0.20 in 2024.